• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮腔内冠状动脉成形术后再狭窄的临床、生理、解剖及操作因素预测

Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.

作者信息

Bourassa M G, Lespérance J, Eastwood C, Schwartz L, Côté G, Kazim F, Hudon G

机构信息

Department of Medicine, Montreal Heart Institute, Quebec, Canada.

出版信息

J Am Coll Cardiol. 1991 Aug;18(2):368-76. doi: 10.1016/0735-1097(91)90588-z.

DOI:10.1016/0735-1097(91)90588-z
PMID:1856404
Abstract

In a recent prospective double-blind placebo-controlled trial, a combination of aspirin and dipyridamole was not associated with a reduction in the rate of restenosis within the 1st 6 months after coronary angioplasty. The purpose of this study was to determine whether clinical, anatomic or procedural factors were predictive of the observed restenosis rates in that prospective trial. A total of 247 patients and 280 segments underwent follow-up angiography and quantitative coronary angiographic analysis between 4 and 7 months after coronary angioplasty. Two baseline clinical characteristics--angina class and duration of angina in months--were related to the rate of restenosis by univariate analysis. Patient-related stepwise logistic regression analysis identified severity of angina as the only clinical predictor of restenosis. Three univariate baseline anatomic characteristics--percent diameter stenosis before angioplasty, stenosis greater than 10 mm in length and calcific stenosis--and two early postangioplasty characteristics--residual percent diameter stenosis and residual mean pressure gradient--were predictive of restenosis. Of these, only two--length of stenosis and residual percent diameter stenosis--were independently related to restenosis by multivariate analysis and only the former is identifiable before the procedure. It is concluded that in prospective studies in contrast to retrospective studies, few clinical and anatomic factors appear to be predictive of restenosis after coronary angioplasty.

摘要

在最近一项前瞻性双盲安慰剂对照试验中,阿司匹林和双嘧达莫联合用药与冠状动脉血管成形术后前6个月内再狭窄率的降低无关。本研究的目的是确定在该前瞻性试验中,临床、解剖或手术因素是否可预测观察到的再狭窄率。共有247例患者和280个节段在冠状动脉血管成形术后4至7个月接受了随访血管造影和定量冠状动脉血管造影分析。通过单因素分析,两个基线临床特征——心绞痛分级和心绞痛持续时间(以月为单位)——与再狭窄率相关。患者相关的逐步逻辑回归分析确定心绞痛严重程度是再狭窄的唯一临床预测因素。三个单因素基线解剖特征——血管成形术前直径狭窄百分比、长度大于10 mm的狭窄和钙化性狭窄——以及两个血管成形术后早期特征——残余直径狭窄百分比和残余平均压力梯度——可预测再狭窄。其中,通过多因素分析,只有两个因素——狭窄长度和残余直径狭窄百分比——与再狭窄独立相关,且只有前者在手术前可识别。结论是,与回顾性研究相比,在前瞻性研究中,几乎没有临床和解剖因素似乎可预测冠状动脉血管成形术后的再狭窄。

相似文献

1
Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术后再狭窄的临床、生理、解剖及操作因素预测
J Am Coll Cardiol. 1991 Aug;18(2):368-76. doi: 10.1016/0735-1097(91)90588-z.
2
Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.高剂量血管紧张素转换酶抑制剂对再狭窄的影响:MARCATOR研究的最终结果,一项关于西拉普利的多中心、双盲、安慰剂对照试验。血管成形术后使用西拉普利预防经腔冠状动脉阻塞和再狭窄的多中心美国研究试验(MARCATOR)研究组
J Am Coll Cardiol. 1995 Feb;25(2):362-9. doi: 10.1016/0735-1097(94)00368-z.
3
Detection of restenosis after successful coronary angioplasty: improved clinical decision making with use of a logistic model combining procedural and follow-up variables.
J Am Coll Cardiol. 1990 Nov;16(6):1333-40. doi: 10.1016/0735-1097(90)90373-w.
4
Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Am Heart J. 1994 Mar;127(3):483-94. doi: 10.1016/0002-8703(94)90654-8.
5
Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.对有再狭窄高风险的患者在冠状动脉血管成形术后进行维拉帕米治疗。
Br Heart J. 1994 Mar;71(3):254-60. doi: 10.1136/hrt.71.3.254.
6
Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.普伐他汀对冠状动脉球囊血管成形术后血管造影再狭窄的影响。PREDICT试验研究者。腔内冠状动脉血管成形术后依立索预防再狭窄。
J Am Coll Cardiol. 1997 Oct;30(4):863-9. doi: 10.1016/s0735-1097(97)00259-3.
7
Effects of diltiazem on complications and restenosis after coronary angioplasty.地尔硫䓬对冠状动脉成形术后并发症及再狭窄的影响。
Am J Cardiol. 1991 Feb 15;67(5):373-6. doi: 10.1016/0002-9149(91)90044-l.
8
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.快速进展性冠状动脉狭窄冠状动脉成形术后再狭窄
Eur Heart J. 1996 Nov;17(11):1671-7. doi: 10.1093/oxfordjournals.eurheartj.a014750.
9
Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.患者、病变及手术相关变量作为成功冠状动脉血管成形术后管腔再狭窄的危险因素:对653例患者778处病变的定量分析。血管成形术后应用西拉普利预防经腔冠状动脉阻塞和再狭窄的多中心欧洲研究试验(MERCATOR)研究组。
J Cardiovasc Pharmacol. 1993;22 Suppl 4:S45-57.
10
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
N Engl J Med. 1988 Jun 30;318(26):1714-9. doi: 10.1056/NEJM198806303182603.

引用本文的文献

1
Validation of complex PCI criteria in drug-coated balloon angioplasty.药物涂层球囊血管成形术中复杂经皮冠状动脉介入治疗标准的验证
Clin Res Cardiol. 2025 May 19. doi: 10.1007/s00392-025-02664-x.
2
Coronary Dissection - Back to the Future - Finding Good in the Bad!冠状动脉夹层——回归未来——在坏事中发现好事!
Heart Int. 2024 Dec 18;18(2):14-23. doi: 10.17925/HI.2024.18.2.5. eCollection 2024.
3
One-Year Outcomes of Long Coronary Drug-Eluting Stents (≥40 MM) in Patients With Diffuse Coronary Artery Disease: Findings From a Tertiary Care Hospital in North India.
长冠状动脉药物洗脱支架(≥40毫米)治疗弥漫性冠状动脉疾病患者的一年结局:来自印度北部一家三级护理医院的研究结果。
Cureus. 2024 May 3;16(5):e59611. doi: 10.7759/cureus.59611. eCollection 2024 May.
4
Comparative treatment outcomes of a single long stent vs. overlapped short stents in acute myocardial infarction.急性心肌梗死中单个长支架与重叠短支架的对比治疗结果
Front Cardiovasc Med. 2023 Dec 19;10:1284396. doi: 10.3389/fcvm.2023.1284396. eCollection 2023.
5
Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents.载有依维莫司的超薄支架治疗动脉粥样硬化病变:最长支架亚组分析的 3 年随访结果
Indian Heart J. 2023 Jul-Aug;75(4):279-284. doi: 10.1016/j.ihj.2023.03.006. Epub 2023 Mar 25.
6
Coronary In-Stent Restenosis: Predictors and Treatment.冠状动脉支架内再狭窄:预测因素与治疗。
Dtsch Arztebl Int. 2021 Sep 24;118(38):637-644. doi: 10.3238/arztebl.m2021.0254.
7
A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.紫杉醇涂层球囊与新一代药物洗脱支架治疗冠状动脉原发病变的血管造影结果的非劣效性、随机临床试验。
Cardiovasc Drugs Ther. 2022 Aug;36(4):655-664. doi: 10.1007/s10557-021-07172-4. Epub 2021 Mar 13.
8
Diffuse Long Coronary Artery Disease is Still an Obstacle for Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era?在第二代药物洗脱支架时代,弥漫性长冠状动脉疾病仍是经皮冠状动脉介入治疗的障碍吗?
Korean Circ J. 2019 Aug;49(8):721-723. doi: 10.4070/kcj.2019.0150. Epub 2019 Jun 19.
9
The effectiveness and safety of the RESTORE drug-eluting balloon versus a drug-eluting stent for small coronary vessel disease: study protocol for a multi-center, randomized, controlled trial.用于小冠状动脉疾病的RESTORE药物洗脱球囊与药物洗脱支架的有效性和安全性:一项多中心、随机、对照试验的研究方案。
J Geriatr Cardiol. 2018 Jul;15(7):469-475. doi: 10.11909/j.issn.1671-5411.2018.07.006.
10
Evaluation of relationship between common carotid artery intima-media thickness and coronary in-stent restenosis: A case-control study.颈总动脉内膜中层厚度与冠状动脉支架内再狭窄关系的评估:一项病例对照研究。
Interv Med Appl Sci. 2018 Mar;10(1):38-44. doi: 10.1556/1646.10.2018.08.